PMH24 ECONOMIC BENEFITS OF ESCITALOPRAM VERSUS DULOXETINE IN SPAIN
Abstract
Authors
N Danchenko N Despigel F Marteau S Herranz del Rey
N Danchenko N Despigel F Marteau S Herranz del Rey
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now